vs
BlackSky Technology Inc.（BKSY）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是BlackSky Technology Inc.的1.0倍（$35.5M vs $35.2M），BlackSky Technology Inc.净利率更高（-2.5% vs -304.2%，领先301.8%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 15.9%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 20.5%）
BlackSky Technology Inc.是一家领先的地理空间情报服务商，运营高重访率小型地球观测卫星星座，为全球政府、国防、关键基础设施及商业客户提供实时卫星影像、高级数据分析与动态监测解决方案，助力各类场景下的运营决策。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BKSY vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.0倍
$35.2M
营收增速更快
RXRX
高出665.8%
15.9%
净利率更高
BKSY
高出301.8%
-304.2%
两年增速更快
RXRX
近两年复合增速
20.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $35.2M | $35.5M |
| 净利润 | $-868.0K | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -11.8% | -304.8% |
| 净利率 | -2.5% | -304.2% |
| 营收同比 | 15.9% | 681.7% |
| 净利润同比 | 95.5% | 39.6% |
| 每股收益（稀释后） | $0.04 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BKSYRXRX
| Q4 25 | $35.2M | $35.5M | ||
| Q3 25 | $19.6M | $5.2M | ||
| Q2 25 | $22.2M | $19.2M | ||
| Q1 25 | $29.5M | $14.7M | ||
| Q4 24 | $30.4M | $4.5M | ||
| Q3 24 | $22.5M | $26.1M | ||
| Q2 24 | $24.9M | $14.4M | ||
| Q1 24 | $24.2M | $13.8M |
净利润BKSYRXRX
| Q4 25 | $-868.0K | $-108.1M | ||
| Q3 25 | $-15.3M | $-162.3M | ||
| Q2 25 | $-41.2M | $-171.9M | ||
| Q1 25 | $-12.8M | $-202.5M | ||
| Q4 24 | $-19.4M | $-178.9M | ||
| Q3 24 | $-12.6M | $-95.8M | ||
| Q2 24 | $-9.4M | $-97.5M | ||
| Q1 24 | $-15.8M | $-91.4M |
毛利率BKSYRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率BKSYRXRX
| Q4 25 | -11.8% | -304.8% | ||
| Q3 25 | -85.8% | -3327.6% | ||
| Q2 25 | -62.8% | -916.8% | ||
| Q1 25 | -40.5% | -1297.9% | ||
| Q4 24 | -20.0% | -4042.4% | ||
| Q3 24 | -58.7% | -377.1% | ||
| Q2 24 | -47.0% | -697.4% | ||
| Q1 24 | -54.7% | -698.4% |
净利率BKSYRXRX
| Q4 25 | -2.5% | -304.2% | ||
| Q3 25 | -78.2% | -3135.3% | ||
| Q2 25 | -185.8% | -894.2% | ||
| Q1 25 | -43.4% | -1373.3% | ||
| Q4 24 | -63.9% | -3935.5% | ||
| Q3 24 | -55.8% | -367.5% | ||
| Q2 24 | -37.7% | -676.6% | ||
| Q1 24 | -65.2% | -662.4% |
每股收益（稀释后）BKSYRXRX
| Q4 25 | $0.04 | $-0.17 | ||
| Q3 25 | $-0.44 | $-0.36 | ||
| Q2 25 | $-1.27 | $-0.41 | ||
| Q1 25 | $-0.42 | $-0.50 | ||
| Q4 24 | $-0.61 | $-0.56 | ||
| Q3 24 | $-0.66 | $-0.34 | ||
| Q2 24 | $-0.52 | $-0.40 | ||
| Q1 24 | $-0.88 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.5M | $743.3M |
| 总债务越低越好 | $201.1M | $9.6M |
| 股东权益账面价值 | $94.9M | $1.1B |
| 总资产 | $386.2M | $1.5B |
| 负债/权益比越低杠杆越低 | 2.12× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资BKSYRXRX
| Q4 25 | $124.5M | $743.3M | ||
| Q3 25 | $146.5M | $659.8M | ||
| Q2 25 | $93.8M | $525.1M | ||
| Q1 25 | $75.8M | $500.5M | ||
| Q4 24 | $52.5M | $594.4M | ||
| Q3 24 | $63.2M | $427.6M | ||
| Q2 24 | $41.2M | $474.3M | ||
| Q1 24 | $35.4M | $296.3M |
总债务BKSYRXRX
| Q4 25 | $201.1M | $9.6M | ||
| Q3 25 | $195.1M | $11.9M | ||
| Q2 25 | $122.5M | $14.2M | ||
| Q1 25 | $115.3M | $16.4M | ||
| Q4 24 | $107.7M | $19.0M | ||
| Q3 24 | $98.8M | $20.5M | ||
| Q2 24 | $108.6M | $22.9M | ||
| Q1 24 | $85.0M | — |
股东权益BKSYRXRX
| Q4 25 | $94.9M | $1.1B | ||
| Q3 25 | $91.1M | $1.0B | ||
| Q2 25 | $86.6M | $919.1M | ||
| Q1 25 | $88.8M | $933.9M | ||
| Q4 24 | $94.0M | $1.0B | ||
| Q3 24 | $110.3M | $524.6M | ||
| Q2 24 | $76.5M | $584.4M | ||
| Q1 24 | $81.7M | $401.2M |
总资产BKSYRXRX
| Q4 25 | $386.2M | $1.5B | ||
| Q3 25 | $380.9M | $1.4B | ||
| Q2 25 | $310.8M | $1.3B | ||
| Q1 25 | $284.9M | $1.3B | ||
| Q4 24 | $254.1M | $1.4B | ||
| Q3 24 | $245.5M | $726.5M | ||
| Q2 24 | $224.3M | $775.9M | ||
| Q1 24 | $210.1M | $557.8M |
负债/权益比BKSYRXRX
| Q4 25 | 2.12× | 0.01× | ||
| Q3 25 | 2.14× | 0.01× | ||
| Q2 25 | 1.41× | 0.02× | ||
| Q1 25 | 1.30× | 0.02× | ||
| Q4 24 | 1.15× | 0.02× | ||
| Q3 24 | 0.90× | 0.04× | ||
| Q2 24 | 1.42× | 0.04× | ||
| Q1 24 | 1.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流BKSYRXRX
| Q4 25 | $-9.3M | $-46.1M | ||
| Q3 25 | $-39.0M | $-117.4M | ||
| Q2 25 | $-7.3M | $-76.4M | ||
| Q1 25 | $27.2M | $-132.0M | ||
| Q4 24 | $-1.8M | $-115.4M | ||
| Q3 24 | $1.0M | $-59.2M | ||
| Q2 24 | $-1.8M | $-82.2M | ||
| Q1 24 | $-3.8M | $-102.3M |
自由现金流BKSYRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率BKSYRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度BKSYRXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
